Abstract

Click reaction of 4,7-dichloroquinoline (1) with thiosemicarbazide (2) to afford the corresponding 2-(7-chloroquinolin-4-yl)thiosemicarbazide (3) utilized ultrasonic irradiation which can cyclized easily with ethylacetoacetate to give the 3-(7-chloroquinolin-4-ylamino)-tetrahydro-6-methyl-2-thioxopyrimidin-4(1H)-one (4) via nucleophilic substitution reaction. The synthesized compounds was examined in vitro antimalarial activity with IC50 = 11.92, 25.37 μg/mL against chloroquinone drug. Furthermore, the theoretical investigation of most active compounds CQT and CQP utilizing of DFT/B3LYP/6-311G(d) and HF/6-311G(d) basis’s set and evaluated their physical characters, bond length, bond angles, dihedral angles, also its HOMO-LUMO energy gap was 3.77 eV which indicate the reactivity of CQP. Moreover, the molecular docking studies of these synthesized compounds showed small energy affinity against SARS-CoV-2 main protease (PDBID: 6lu7) and crystal structure of thermoplasma acidophilum (PDBID: 1q2w) and shorter bond length. All these parameters could be considered with different extent to significantly affect the binding affinity of these compounds to the active protein sites for further biological evaluation on Covid-19.

Highlights

  • In December 2019, several cases of pneumonia of an unknown etiology appeared in Wuhan, Hubei Province, China

  • On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) named the virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This is the seventh member of the coronavirus family that can infect humans after the appearance of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

  • The World Health Organization classified the coronavirus pneumonia epidemic caused by SARSCoV-2 as a public health emergency of international concern on January 30, 2020 (Zhao et al, 2010; Zhou et al, 2020)

Read more

Summary

Introduction

In December 2019, several cases of pneumonia of an unknown etiology appeared in Wuhan, Hubei Province, China. A novel coronavirus was identified in a bronchoalveolar lavage fluid sample from the Wuhan Seafood Market through the use of metagenomic nextgeneration sequencing technology (Yang and Wang, 2020; Wu et al, 2020a). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) named the virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This is the seventh member of the coronavirus family that can infect humans after the appearance of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Etiology of SARS-COV-2 Corona viruses are not new infectious pathogens in the world.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call